Expression of the small peptide GLP-1 in transgenic plants

被引:58
|
作者
Yasuda, H
Tada, Y
Hayashi, Y
Jomori, T
Takaiwa, F
机构
[1] Natl Inst Agrobiol Sci, Dept Plant Biotechnol, Tsukuba, Ibaraki 3058602, Japan
[2] Sanwa Kagaku Kenkyusyo Co Ltd, Inabe, Mie 5110406, Japan
关键词
co-suppression; GLP-1; 2A sequence; transgenic rice;
D O I
10.1007/s11248-005-6631-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy. In order to accumulate GLP-1 in endosperm tissue of rice, a codon-optimized GLP-1 (mGLP-1) synthetic gene was directly expressed under the control of rice storage protein glutelin GluB-1 promoter in transgenic rice plants. Unexpectedly, neither the transcripts nor the transgene products were detected in the seeds of regenerated plants. Furthermore, transcripts of GluB-1 gene in these transgenic plants were not detected, and small interfering RNAs (siRNAs) corresponding to the transgene were detected. These results indicated that the expression of mGLP-1 was silenced by co-suppression in rice transgenic seeds. To avoid silencing, mGLP-1 was fused to GFP with or without self-processing 2A sequence, and introduced into rice plants. Both chimeric genes were highly expressed in these transgenic rice seeds, indicating that gene silencing could be avoided by changing the transgene components. Furthermore, the fusion protein containing the 2A sequence were processed into GFP-2A and mGLP-1 peptides with the efficiency of more than 80%, but the processed mGLP-1 peptides were not detected. Lack of accumulation of mGLP-1 may be explained by proteolytic digestion in the cytoplasm.
引用
收藏
页码:677 / 684
页数:8
相关论文
共 50 条
  • [41] Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats
    Isabel Valverde
    Gen-Sheng Wang
    Karolina Burghardt
    Lisa M. Kauri
    Araceli Redondo
    Alicia Acitores
    Maria L. Villanueva-Peñacarrillo
    Philippe Courtois
    Abdullah Sener
    Jesús Cancelas
    Willy J. Malaisse
    Fraser W. Scott
    Endocrine, 2004, 23 : 77 - 84
  • [42] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [43] GLP-1 in NIDDM
    Holst, JJ
    DIABETIC MEDICINE, 1996, 13 (09) : S156 - S160
  • [44] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [45] Identification of glucagon like peptide-1 (GLP-1) in mice stomach
    Otsuka, Manami
    Huang, Jin
    Tanaka, Toru
    Sakata, Ichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 704
  • [46] The role of glucagon-like peptide 1 (GLP-1) in addictive disorders
    Kruse Klausen, Mette
    Thomsen, Morgane
    Wortwein, Gitta
    Fink-Jensen, Anders
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 625 - 641
  • [47] GLP-1 and the gut
    Thompson, DG
    GUT, 2000, 46 (05) : 591 - 591
  • [48] Obesity and GLP-1
    De Oca, Alejandra Perez-Montes
    Pellitero, Silvia
    Puig-Domingo, Manel
    MINERVA ENDOCRINOLOGY, 2021, 46 (02): : 168 - 176
  • [50] Studies on glucagon like peptide-1 (GLP-1) analogues: a review
    Jiang J.-Q.
    Fu L.
    Tan M.-L.
    Chen S.-F.
    Gao Xiao Hua Xue Gong Cheng Xue Bao/Journal of Chemical Engineering of Chinese Universities, 2020, 34 (06): : 1327 - 1338